nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—XDH—Doxorubicin—liver cancer	0.429	0.601	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—liver cancer	0.285	0.399	CbGbCtD
Procarbazine—Acute myeloid leukaemia—Epirubicin—liver cancer	0.00492	0.026	CcSEcCtD
Procarbazine—Ascites—Sorafenib—liver cancer	0.00481	0.0254	CcSEcCtD
Procarbazine—Acute myeloid leukaemia—Doxorubicin—liver cancer	0.00455	0.024	CcSEcCtD
Procarbazine—Metastatic neoplasm—Epirubicin—liver cancer	0.00421	0.0222	CcSEcCtD
Procarbazine—Metastatic neoplasm—Doxorubicin—liver cancer	0.0039	0.0206	CcSEcCtD
Procarbazine—XDH—Oxidative Stress—NFE2L2—liver cancer	0.00351	0.0366	CbGpPWpGaD
Procarbazine—Cardiotoxicity—Epirubicin—liver cancer	0.00343	0.0181	CcSEcCtD
Procarbazine—XDH—Oxidative Stress—GPX3—liver cancer	0.00335	0.0349	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTA1—liver cancer	0.00321	0.0335	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—EPT1—liver cancer	0.0032	0.0334	CbGpPWpGaD
Procarbazine—Cardiotoxicity—Doxorubicin—liver cancer	0.00317	0.0167	CcSEcCtD
Procarbazine—CYP1B1—Endogenous sterols—NR1H4—liver cancer	0.00312	0.0325	CbGpPWpGaD
Procarbazine—Azoospermia—Epirubicin—liver cancer	0.003	0.0158	CcSEcCtD
Procarbazine—Pleural effusion—Sorafenib—liver cancer	0.00285	0.0151	CcSEcCtD
Procarbazine—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00284	0.0297	CbGpPWpGaD
Procarbazine—Acute leukaemia—Epirubicin—liver cancer	0.00283	0.0149	CcSEcCtD
Procarbazine—Azoospermia—Doxorubicin—liver cancer	0.00277	0.0146	CcSEcCtD
Procarbazine—Dysphonia—Sorafenib—liver cancer	0.00266	0.014	CcSEcCtD
Procarbazine—Acute leukaemia—Doxorubicin—liver cancer	0.00261	0.0138	CcSEcCtD
Procarbazine—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.00259	0.027	CbGpPWpGaD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00259	0.027	CbGpPWpGaD
Procarbazine—Neoplasm malignant—Sorafenib—liver cancer	0.00256	0.0135	CcSEcCtD
Procarbazine—XDH—Oxidative Stress—HMOX1—liver cancer	0.00209	0.0218	CbGpPWpGaD
Procarbazine—Neuropathy—Sorafenib—liver cancer	0.00205	0.0108	CcSEcCtD
Procarbazine—Gynaecomastia—Sorafenib—liver cancer	0.00195	0.0103	CcSEcCtD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—CYP1A1—liver cancer	0.00193	0.0201	CbGpPWpGaD
Procarbazine—Pericarditis—Epirubicin—liver cancer	0.00187	0.00985	CcSEcCtD
Procarbazine—XDH—Oxidative Stress—CYP1A1—liver cancer	0.00184	0.0192	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP2E1—liver cancer	0.00183	0.0191	CbGpPWpGaD
Procarbazine—Hepatic function abnormal—Sorafenib—liver cancer	0.00181	0.00958	CcSEcCtD
Procarbazine—Ascites—Epirubicin—liver cancer	0.00178	0.00938	CcSEcCtD
Procarbazine—Hyporeflexia—Epirubicin—liver cancer	0.00178	0.00938	CcSEcCtD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—PPARA—liver cancer	0.00176	0.0184	CbGpPWpGaD
Procarbazine—Pericarditis—Doxorubicin—liver cancer	0.00173	0.00912	CcSEcCtD
Procarbazine—Ascites—Doxorubicin—liver cancer	0.00164	0.00868	CcSEcCtD
Procarbazine—Hyporeflexia—Doxorubicin—liver cancer	0.00164	0.00868	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12A—liver cancer	0.00161	0.0168	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—ESR1—liver cancer	0.0016	0.0167	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—GSTA2—liver cancer	0.00157	0.0164	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTM1—liver cancer	0.00157	0.0163	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—MAPK14—liver cancer	0.00156	0.0162	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—CYP1A1—liver cancer	0.00149	0.0155	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00145	0.0151	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00143	0.00754	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—GPX3—liver cancer	0.00141	0.0148	CbGpPWpGaD
Procarbazine—Dysphagia—Sorafenib—liver cancer	0.00137	0.00723	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.00137	0.0143	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00137	0.0143	CbGpPWpGaD
Procarbazine—Skin hyperpigmentation—Epirubicin—liver cancer	0.00136	0.00717	CcSEcCtD
Procarbazine—Pancreatitis—Sorafenib—liver cancer	0.00134	0.00709	CcSEcCtD
Procarbazine—Febrile neutropenia—Epirubicin—liver cancer	0.00134	0.00708	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00133	0.0139	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.00133	0.0139	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP1A1—liver cancer	0.00131	0.0137	CbGpPWpGaD
Procarbazine—Optic neuritis—Epirubicin—liver cancer	0.00131	0.00693	CcSEcCtD
Procarbazine—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00126	0.00663	CcSEcCtD
Procarbazine—Febrile neutropenia—Doxorubicin—liver cancer	0.00124	0.00655	CcSEcCtD
Procarbazine—Pneumonia—Sorafenib—liver cancer	0.00123	0.00649	CcSEcCtD
Procarbazine—Optic neuritis—Doxorubicin—liver cancer	0.00121	0.00641	CcSEcCtD
Procarbazine—Neuropathy peripheral—Sorafenib—liver cancer	0.0012	0.00632	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.0012	0.0125	CbGpPWpGaD
Procarbazine—Stomatitis—Sorafenib—liver cancer	0.00119	0.00629	CcSEcCtD
Procarbazine—Jaundice—Sorafenib—liver cancer	0.00119	0.00629	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00117	0.0123	CbGpPWpGaD
Procarbazine—Haematemesis—Epirubicin—liver cancer	0.00116	0.00613	CcSEcCtD
Procarbazine—Epistaxis—Sorafenib—liver cancer	0.00115	0.00608	CcSEcCtD
Procarbazine—Thrombosis—Epirubicin—liver cancer	0.00114	0.00602	CcSEcCtD
Procarbazine—Nystagmus—Epirubicin—liver cancer	0.00113	0.00597	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—HPGDS—liver cancer	0.00112	0.0117	CbGpPWpGaD
Procarbazine—Haemoglobin—Sorafenib—liver cancer	0.0011	0.00582	CcSEcCtD
Procarbazine—Haemorrhage—Sorafenib—liver cancer	0.0011	0.00579	CcSEcCtD
Procarbazine—Haemoptysis—Epirubicin—liver cancer	0.00109	0.00576	CcSEcCtD
Procarbazine—Haematemesis—Doxorubicin—liver cancer	0.00108	0.00568	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—UGDH—liver cancer	0.00107	0.0111	CbGpPWpGaD
Procarbazine—Thrombosis—Doxorubicin—liver cancer	0.00106	0.00557	CcSEcCtD
Procarbazine—Pleural effusion—Epirubicin—liver cancer	0.00105	0.00557	CcSEcCtD
Procarbazine—Nystagmus—Doxorubicin—liver cancer	0.00105	0.00552	CcSEcCtD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—JUN—liver cancer	0.00103	0.0108	CbGpPWpGaD
Procarbazine—Flushing—Sorafenib—liver cancer	0.00102	0.00537	CcSEcCtD
Procarbazine—CYP1B1—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00101	0.0106	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00101	0.0106	CbGpPWpGaD
Procarbazine—Haemoptysis—Doxorubicin—liver cancer	0.00101	0.00533	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—GGT1—liver cancer	0.000996	0.0104	CbGpPWpGaD
Procarbazine—Petechiae—Epirubicin—liver cancer	0.000981	0.00518	CcSEcCtD
Procarbazine—Dysphonia—Epirubicin—liver cancer	0.000981	0.00518	CcSEcCtD
Procarbazine—Arrhythmia—Sorafenib—liver cancer	0.00098	0.00517	CcSEcCtD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP2E1—liver cancer	0.000976	0.0102	CbGpPWpGaD
Procarbazine—Pleural effusion—Doxorubicin—liver cancer	0.000975	0.00515	CcSEcCtD
Procarbazine—Alopecia—Sorafenib—liver cancer	0.000969	0.00512	CcSEcCtD
Procarbazine—Neoplasm malignant—Epirubicin—liver cancer	0.000945	0.00499	CcSEcCtD
Procarbazine—Ibuprofen—PPARG—liver cancer	0.000927	0.727	CrCbGaD
Procarbazine—Amenorrhoea—Epirubicin—liver cancer	0.000919	0.00485	CcSEcCtD
Procarbazine—Petechiae—Doxorubicin—liver cancer	0.000908	0.00479	CcSEcCtD
Procarbazine—Dysphonia—Doxorubicin—liver cancer	0.000908	0.00479	CcSEcCtD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—STAT3—liver cancer	0.000894	0.00933	CbGpPWpGaD
Procarbazine—Anaemia—Sorafenib—liver cancer	0.000883	0.00466	CcSEcCtD
Procarbazine—Neoplasm malignant—Doxorubicin—liver cancer	0.000875	0.00462	CcSEcCtD
Procarbazine—Nocturia—Epirubicin—liver cancer	0.00087	0.00459	CcSEcCtD
Procarbazine—Syncope—Sorafenib—liver cancer	0.000856	0.00452	CcSEcCtD
Procarbazine—Leukopenia—Sorafenib—liver cancer	0.000855	0.00451	CcSEcCtD
Procarbazine—Dysarthria—Epirubicin—liver cancer	0.000854	0.00451	CcSEcCtD
Procarbazine—Amenorrhoea—Doxorubicin—liver cancer	0.00085	0.00449	CcSEcCtD
Procarbazine—Loss of consciousness—Sorafenib—liver cancer	0.000839	0.00443	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—GGT1—liver cancer	0.000838	0.00875	CbGpPWpGaD
Procarbazine—Cough—Sorafenib—liver cancer	0.000833	0.0044	CcSEcCtD
Procarbazine—Hypertension—Sorafenib—liver cancer	0.000825	0.00435	CcSEcCtD
Procarbazine—Arthralgia—Sorafenib—liver cancer	0.000813	0.00429	CcSEcCtD
Procarbazine—Myalgia—Sorafenib—liver cancer	0.000813	0.00429	CcSEcCtD
Procarbazine—Nocturia—Doxorubicin—liver cancer	0.000805	0.00425	CcSEcCtD
Procarbazine—Dry mouth—Sorafenib—liver cancer	0.000795	0.0042	CcSEcCtD
Procarbazine—Dysarthria—Doxorubicin—liver cancer	0.00079	0.00417	CcSEcCtD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000789	0.00823	CbGpPWpGaD
Procarbazine—Melaena—Epirubicin—liver cancer	0.000789	0.00416	CcSEcCtD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000779	0.00813	CbGpPWpGaD
Procarbazine—Infection—Sorafenib—liver cancer	0.000774	0.00409	CcSEcCtD
Procarbazine—Shock—Sorafenib—liver cancer	0.000767	0.00405	CcSEcCtD
Procarbazine—Thrombocytopenia—Sorafenib—liver cancer	0.000763	0.00403	CcSEcCtD
Procarbazine—Neuropathy—Epirubicin—liver cancer	0.000758	0.004	CcSEcCtD
Procarbazine—Anorexia—Sorafenib—liver cancer	0.000743	0.00392	CcSEcCtD
Procarbazine—Coma—Epirubicin—liver cancer	0.000738	0.00389	CcSEcCtD
Procarbazine—Melaena—Doxorubicin—liver cancer	0.00073	0.00385	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—MTHFR—liver cancer	0.000726	0.00758	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00071	0.00375	CcSEcCtD
Procarbazine—Neuropathy—Doxorubicin—liver cancer	0.000701	0.0037	CcSEcCtD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP1A1—liver cancer	0.000701	0.00732	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.000701	0.00732	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.000701	0.00732	CbGpPWpGaD
Procarbazine—Coma—Doxorubicin—liver cancer	0.000683	0.0036	CcSEcCtD
Procarbazine—Decreased appetite—Sorafenib—liver cancer	0.000678	0.00358	CcSEcCtD
Procarbazine—Fatigue—Sorafenib—liver cancer	0.000672	0.00355	CcSEcCtD
Procarbazine—Hepatic function abnormal—Epirubicin—liver cancer	0.000671	0.00354	CcSEcCtD
Procarbazine—Photosensitivity—Epirubicin—liver cancer	0.000667	0.00352	CcSEcCtD
Procarbazine—Pain—Sorafenib—liver cancer	0.000667	0.00352	CcSEcCtD
Procarbazine—Constipation—Sorafenib—liver cancer	0.000667	0.00352	CcSEcCtD
Procarbazine—CYP1B1—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000656	0.00684	CbGpPWpGaD
Procarbazine—Vascular purpura—Epirubicin—liver cancer	0.000655	0.00346	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00064	0.00668	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—F2—liver cancer	0.000638	0.00665	CbGpPWpGaD
Procarbazine—Gastrointestinal pain—Sorafenib—liver cancer	0.000637	0.00336	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—NR1H4—liver cancer	0.000624	0.00651	CbGpPWpGaD
Procarbazine—Hepatic function abnormal—Doxorubicin—liver cancer	0.00062	0.00328	CcSEcCtD
Procarbazine—Urticaria—Sorafenib—liver cancer	0.000619	0.00327	CcSEcCtD
Procarbazine—Photosensitivity—Doxorubicin—liver cancer	0.000618	0.00326	CcSEcCtD
Procarbazine—Abdominal pain—Sorafenib—liver cancer	0.000616	0.00325	CcSEcCtD
Procarbazine—Body temperature increased—Sorafenib—liver cancer	0.000616	0.00325	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTA3—liver cancer	0.000613	0.0064	CbGpPWpGaD
Procarbazine—Purpura—Epirubicin—liver cancer	0.000608	0.00321	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—liver cancer	0.000606	0.0032	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTA3—liver cancer	0.000605	0.00631	CbGpPWpGaD
Procarbazine—Lethargy—Epirubicin—liver cancer	0.000598	0.00316	CcSEcCtD
Procarbazine—Diplopia—Epirubicin—liver cancer	0.000586	0.00309	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000581	0.00606	CbGpPWpGaD
Procarbazine—Hypersensitivity—Sorafenib—liver cancer	0.000574	0.00303	CcSEcCtD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000567	0.00592	CbGpPWpGaD
Procarbazine—Purpura—Doxorubicin—liver cancer	0.000563	0.00297	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTA4—liver cancer	0.000561	0.00585	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00056	0.00584	CbGpPWpGaD
Procarbazine—Asthenia—Sorafenib—liver cancer	0.000559	0.00295	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—liver cancer	0.000553	0.00292	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTA4—liver cancer	0.000553	0.00577	CbGpPWpGaD
Procarbazine—Pruritus—Sorafenib—liver cancer	0.000551	0.00291	CcSEcCtD
Procarbazine—Ataxia—Epirubicin—liver cancer	0.000551	0.00291	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTA2—liver cancer	0.000547	0.0057	CbGpPWpGaD
Procarbazine—Diplopia—Doxorubicin—liver cancer	0.000542	0.00286	CcSEcCtD
Procarbazine—Diarrhoea—Sorafenib—liver cancer	0.000533	0.00282	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000531	0.00554	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALB—liver cancer	0.00053	0.00553	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000528	0.00279	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTA1—liver cancer	0.000527	0.0055	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—NAT2—liver cancer	0.000521	0.00544	CbGpPWpGaD
Procarbazine—Dizziness—Sorafenib—liver cancer	0.000515	0.00272	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—NAT2—liver cancer	0.000514	0.00537	CbGpPWpGaD
Procarbazine—Ataxia—Doxorubicin—liver cancer	0.00051	0.00269	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—liver cancer	0.000507	0.00267	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—liver cancer	0.000502	0.00265	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—liver cancer	0.000497	0.00262	CcSEcCtD
Procarbazine—Vomiting—Sorafenib—liver cancer	0.000496	0.00262	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—liver cancer	0.000493	0.0026	CcSEcCtD
Procarbazine—Rash—Sorafenib—liver cancer	0.000491	0.00259	CcSEcCtD
Procarbazine—Dermatitis—Sorafenib—liver cancer	0.000491	0.00259	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000488	0.00258	CcSEcCtD
Procarbazine—Headache—Sorafenib—liver cancer	0.000488	0.00258	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—liver cancer	0.000481	0.00254	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—liver cancer	0.000469	0.00247	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—liver cancer	0.000468	0.00247	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—liver cancer	0.000464	0.00245	CcSEcCtD
Procarbazine—Nausea—Sorafenib—liver cancer	0.000463	0.00244	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—liver cancer	0.000462	0.00244	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00046	0.0048	CbGpPWpGaD
Procarbazine—Pancreatitis—Doxorubicin—liver cancer	0.00046	0.00243	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—liver cancer	0.000457	0.00241	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—liver cancer	0.000454	0.0024	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—liver cancer	0.000452	0.00238	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—liver cancer	0.000445	0.00235	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—liver cancer	0.000443	0.00234	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—liver cancer	0.00044	0.00232	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—liver cancer	0.00044	0.00232	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GPX3—liver cancer	0.000437	0.00456	CbGpPWpGaD
Procarbazine—Sweating—Epirubicin—liver cancer	0.000433	0.00229	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—liver cancer	0.000433	0.00229	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000431	0.0045	CbGpPWpGaD
Procarbazine—Haematuria—Epirubicin—liver cancer	0.000431	0.00227	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000428	0.00226	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—liver cancer	0.000426	0.00225	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—liver cancer	0.00042	0.00222	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—liver cancer	0.000418	0.00221	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—HPGDS—liver cancer	0.000417	0.00435	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00041	0.00216	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—liver cancer	0.000407	0.00215	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—liver cancer	0.000407	0.00215	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—liver cancer	0.000407	0.00215	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—liver cancer	0.000405	0.00214	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—liver cancer	0.000401	0.00211	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—liver cancer	0.000398	0.0021	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000395	0.00412	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000395	0.00412	CbGpPWpGaD
Procarbazine—Epistaxis—Doxorubicin—liver cancer	0.000394	0.00208	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000387	0.00403	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000386	0.00402	CbGpPWpGaD
Procarbazine—Haemoglobin—Doxorubicin—liver cancer	0.000377	0.00199	CcSEcCtD
Procarbazine—Flushing—Epirubicin—liver cancer	0.000376	0.00199	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000376	0.00392	CbGpPWpGaD
Procarbazine—Haemorrhage—Doxorubicin—liver cancer	0.000375	0.00198	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000365	0.0038	CbGpPWpGaD
Procarbazine—Chills—Epirubicin—liver cancer	0.000364	0.00192	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—liver cancer	0.000362	0.00191	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—liver cancer	0.000358	0.00189	CcSEcCtD
Procarbazine—Ibuprofen—ALB—liver cancer	0.000349	0.273	CrCbGaD
Procarbazine—Flushing—Doxorubicin—liver cancer	0.000348	0.00184	CcSEcCtD
Procarbazine—Tension—Epirubicin—liver cancer	0.000346	0.00183	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—liver cancer	0.000343	0.00181	CcSEcCtD
Procarbazine—XDH—Metabolism—UGDH—liver cancer	0.000341	0.00356	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP2E1—liver cancer	0.00034	0.00355	CbGpPWpGaD
Procarbazine—Chills—Doxorubicin—liver cancer	0.000337	0.00178	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP2E1—liver cancer	0.000335	0.0035	CbGpPWpGaD
Procarbazine—Arrhythmia—Doxorubicin—liver cancer	0.000335	0.00177	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—liver cancer	0.000331	0.00175	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000329	0.00343	CbGpPWpGaD
Procarbazine—Anaemia—Epirubicin—liver cancer	0.000326	0.00172	CcSEcCtD
Procarbazine—XDH—Metabolism—EPT1—liver cancer	0.000321	0.00334	CbGpPWpGaD
Procarbazine—Tension—Doxorubicin—liver cancer	0.00032	0.00169	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—liver cancer	0.000317	0.00167	CcSEcCtD
Procarbazine—Syncope—Epirubicin—liver cancer	0.000317	0.00167	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—liver cancer	0.000316	0.00167	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—TNF—liver cancer	0.000313	0.00326	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GGT1—liver cancer	0.000312	0.00326	CbGpPWpGaD
Procarbazine—Loss of consciousness—Epirubicin—liver cancer	0.00031	0.00164	CcSEcCtD
Procarbazine—Cough—Epirubicin—liver cancer	0.000308	0.00163	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—liver cancer	0.000306	0.00161	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—liver cancer	0.000305	0.00161	CcSEcCtD
Procarbazine—XDH—Metabolism—TAT—liver cancer	0.000304	0.00317	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000302	0.00315	CbGpPWpGaD
Procarbazine—Anaemia—Doxorubicin—liver cancer	0.000302	0.00159	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000302	0.00315	CbGpPWpGaD
Procarbazine—Arthralgia—Epirubicin—liver cancer	0.0003	0.00159	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—liver cancer	0.0003	0.00159	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—liver cancer	0.000299	0.00158	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—liver cancer	0.000294	0.00155	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—liver cancer	0.000293	0.00155	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—liver cancer	0.000292	0.00154	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—liver cancer	0.00029	0.00153	CcSEcCtD
Procarbazine—Oedema—Epirubicin—liver cancer	0.000288	0.00152	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—liver cancer	0.000287	0.00152	CcSEcCtD
Procarbazine—Infection—Epirubicin—liver cancer	0.000286	0.00151	CcSEcCtD
Procarbazine—Cough—Doxorubicin—liver cancer	0.000285	0.0015	CcSEcCtD
Procarbazine—Shock—Epirubicin—liver cancer	0.000283	0.0015	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—liver cancer	0.000283	0.00149	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—liver cancer	0.000282	0.00149	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—liver cancer	0.000282	0.00149	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000282	0.00294	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000282	0.00294	CbGpPWpGaD
Procarbazine—Tachycardia—Epirubicin—liver cancer	0.000281	0.00148	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTP1—liver cancer	0.00028	0.00292	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000279	0.00291	CbGpPWpGaD
Procarbazine—Hyperhidrosis—Epirubicin—liver cancer	0.000278	0.00147	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—liver cancer	0.000278	0.00147	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—liver cancer	0.000278	0.00147	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—liver cancer	0.000277	0.00146	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTP1—liver cancer	0.000276	0.00288	CbGpPWpGaD
Procarbazine—Anorexia—Epirubicin—liver cancer	0.000275	0.00145	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—liver cancer	0.000272	0.00144	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—liver cancer	0.000269	0.00142	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—liver cancer	0.000269	0.00142	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—liver cancer	0.000267	0.00141	CcSEcCtD
Procarbazine—Infection—Doxorubicin—liver cancer	0.000265	0.0014	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000262	0.00139	CcSEcCtD
Procarbazine—Shock—Doxorubicin—liver cancer	0.000262	0.00138	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—liver cancer	0.000261	0.00138	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—liver cancer	0.000261	0.00138	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—liver cancer	0.00026	0.00137	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—liver cancer	0.000259	0.00137	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—liver cancer	0.000258	0.00136	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTM1—liver cancer	0.000258	0.00269	CbGpPWpGaD
Procarbazine—Somnolence—Epirubicin—liver cancer	0.000256	0.00135	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—liver cancer	0.000254	0.00134	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM1—liver cancer	0.000254	0.00265	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—IL6—liver cancer	0.000252	0.00263	CbGpPWpGaD
Procarbazine—Decreased appetite—Epirubicin—liver cancer	0.00025	0.00132	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—liver cancer	0.000249	0.00131	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000248	0.00259	CbGpPWpGaD
Procarbazine—Fatigue—Epirubicin—liver cancer	0.000248	0.00131	CcSEcCtD
Procarbazine—Pain—Epirubicin—liver cancer	0.000246	0.0013	CcSEcCtD
Procarbazine—Constipation—Epirubicin—liver cancer	0.000246	0.0013	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP1A1—liver cancer	0.000244	0.00255	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000243	0.00128	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—liver cancer	0.000241	0.00127	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP1A1—liver cancer	0.000241	0.00251	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00024	0.0025	CbGpPWpGaD
Procarbazine—Paraesthesia—Doxorubicin—liver cancer	0.000239	0.00126	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000237	0.00248	CbGpPWpGaD
Procarbazine—Feeling abnormal—Epirubicin—liver cancer	0.000237	0.00125	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—liver cancer	0.000237	0.00125	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—liver cancer	0.000236	0.00124	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—liver cancer	0.000232	0.00122	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—liver cancer	0.00023	0.00121	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—liver cancer	0.000229	0.00121	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—liver cancer	0.000228	0.0012	CcSEcCtD
Procarbazine—Pain—Doxorubicin—liver cancer	0.000228	0.0012	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—liver cancer	0.000228	0.0012	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—liver cancer	0.000228	0.0012	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—liver cancer	0.00022	0.00116	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000218	0.00115	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—liver cancer	0.000212	0.00112	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—liver cancer	0.000212	0.00112	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—liver cancer	0.000211	0.00111	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—liver cancer	0.000211	0.00111	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—liver cancer	0.000207	0.00109	CcSEcCtD
Procarbazine—XDH—Metabolism—CPT1B—liver cancer	0.000207	0.00216	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GLUL—liver cancer	0.000207	0.00216	CbGpPWpGaD
Procarbazine—Pruritus—Epirubicin—liver cancer	0.000204	0.00108	CcSEcCtD
Procarbazine—XDH—Metabolism—NR1H4—liver cancer	0.000199	0.00208	CbGpPWpGaD
Procarbazine—Diarrhoea—Epirubicin—liver cancer	0.000197	0.00104	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—liver cancer	0.000196	0.00104	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA3—liver cancer	0.000196	0.00204	CbGpPWpGaD
Procarbazine—Asthenia—Doxorubicin—liver cancer	0.000191	0.00101	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—liver cancer	0.00019	0.00101	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—liver cancer	0.000189	0.000995	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000183	0.00191	CbGpPWpGaD
Procarbazine—Vomiting—Epirubicin—liver cancer	0.000183	0.000967	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—UGDH—liver cancer	0.000183	0.00191	CbGpPWpGaD
Procarbazine—Diarrhoea—Doxorubicin—liver cancer	0.000182	0.000963	CcSEcCtD
Procarbazine—Rash—Epirubicin—liver cancer	0.000182	0.000959	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—liver cancer	0.000181	0.000958	CcSEcCtD
Procarbazine—Headache—Epirubicin—liver cancer	0.00018	0.000953	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA4—liver cancer	0.000179	0.00187	CbGpPWpGaD
Procarbazine—Dizziness—Doxorubicin—liver cancer	0.000176	0.00093	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA2—liver cancer	0.000175	0.00182	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—EPT1—liver cancer	0.000172	0.00179	CbGpPWpGaD
Procarbazine—Nausea—Epirubicin—liver cancer	0.000171	0.000903	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—liver cancer	0.000169	0.000895	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA1—liver cancer	0.000168	0.00176	CbGpPWpGaD
Procarbazine—Rash—Doxorubicin—liver cancer	0.000168	0.000887	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—liver cancer	0.000168	0.000886	CcSEcCtD
Procarbazine—Headache—Doxorubicin—liver cancer	0.000167	0.000881	CcSEcCtD
Procarbazine—XDH—Metabolism—NAT2—liver cancer	0.000166	0.00174	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—TAT—liver cancer	0.000163	0.0017	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00016	0.00167	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALDOB—liver cancer	0.00016	0.00167	CbGpPWpGaD
Procarbazine—Nausea—Doxorubicin—liver cancer	0.000158	0.000836	CcSEcCtD
Procarbazine—XDH—Metabolism—CRABP1—liver cancer	0.000152	0.00159	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HPGDS—liver cancer	0.000133	0.00139	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00012	0.00125	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PSMA4—liver cancer	0.000119	0.00124	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PSMD10—liver cancer	0.000119	0.00124	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GOT2—liver cancer	0.000115	0.0012	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GLUL—liver cancer	0.000111	0.00115	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CPT1B—liver cancer	0.000111	0.00115	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP2E1—liver cancer	0.000108	0.00113	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NR1H4—liver cancer	0.000107	0.00111	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA3—liver cancer	0.000105	0.00109	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYCS—liver cancer	0.000102	0.00106	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GOT1—liver cancer	9.96e-05	0.00104	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GGT1—liver cancer	9.96e-05	0.00104	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA4—liver cancer	9.59e-05	0.001	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.38e-05	0.000978	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA2—liver cancer	9.35e-05	0.000975	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA1—liver cancer	9.02e-05	0.000941	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTP1—liver cancer	8.95e-05	0.000934	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NAT2—liver cancer	8.92e-05	0.00093	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HMOX1—liver cancer	8.82e-05	0.000921	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.58e-05	0.000895	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALDOB—liver cancer	8.55e-05	0.000892	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTM1—liver cancer	8.22e-05	0.000858	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CRABP1—liver cancer	8.16e-05	0.000851	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP1A1—liver cancer	7.79e-05	0.000813	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.34e-05	0.000766	CbGpPWpGaD
Procarbazine—XDH—Metabolism—MTHFR—liver cancer	7.27e-05	0.000758	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HPGDS—liver cancer	7.13e-05	0.000744	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PPARA—liver cancer	7.13e-05	0.000744	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.09e-05	0.00074	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.46e-05	0.000674	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.37e-05	0.000665	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PSMD10—liver cancer	6.35e-05	0.000663	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PSMA4—liver cancer	6.35e-05	0.000663	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GOT2—liver cancer	6.18e-05	0.000645	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CG—liver cancer	6.11e-05	0.000637	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PPARG—liver cancer	5.89e-05	0.000615	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP2E1—liver cancer	5.81e-05	0.000606	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.63e-05	0.000587	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYCS—liver cancer	5.44e-05	0.000567	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CD—liver cancer	5.37e-05	0.00056	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GOT1—liver cancer	5.34e-05	0.000557	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GGT1—liver cancer	5.34e-05	0.000557	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALB—liver cancer	5.3e-05	0.000553	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTP1—liver cancer	4.79e-05	0.0005	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HMOX1—liver cancer	4.73e-05	0.000493	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CB—liver cancer	4.68e-05	0.000488	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM1—liver cancer	4.4e-05	0.00046	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP1A1—liver cancer	4.18e-05	0.000436	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MTHFR—liver cancer	3.89e-05	0.000406	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPARA—liver cancer	3.82e-05	0.000398	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.43e-05	0.000358	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CG—liver cancer	3.27e-05	0.000341	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPARG—liver cancer	3.16e-05	0.000329	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CD—liver cancer	2.88e-05	0.0003	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CA—liver cancer	2.85e-05	0.000298	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALB—liver cancer	2.84e-05	0.000296	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CB—liver cancer	2.51e-05	0.000261	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKT1—liver cancer	2.33e-05	0.000243	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CA—liver cancer	1.53e-05	0.000159	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKT1—liver cancer	1.25e-05	0.00013	CbGpPWpGaD
